Former Union Minister Ramchandra Prasad Singh on Saturday (June 27, 2026) met Janata Dal (United) National President and former Bihar Chief Minister Nitish Kumar at his residence in Patna after nearly ...
Singh, a former JD(U) national president, resigned from the party in 2022 after reportedly joining the Union Cabinet in 2019 without Nitish Kumar's consent. PATNA: Former Union minister RCP Singh on ...
Prince Harry's spokesperson has issued a fiery statement in response to numerous reports about the duke's security when he returns to the UK next week. He has vowed to look at 'all options' to allow ...
Patna, Bihar | JD(U) MP and Party's National Working President Sanjay Kumar Jha says, “Nitish Kumar was already elected as the National President in yesterday's meeting and was endorsed in the ...
Akshay Kumar headlines Welcome to the Jungle, marking his return to the franchise after being absent from the 2015 sequel Welcome Back. Original cast members Anil Kapoor and Nana Patekar are not part ...
MUMBAI- Bollywood actors Akshay Kumar and Karan Johar are set to return with the second season of ‘Pitch To Get Rich’, a fashion-focused business reality show aimed at discovering and nurturing the ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
The third instalment in the 'Welcome' franchise, 'Welcome to the Jungle', marks the return of the beloved comedy series with an even bigger scale, grander action, and a massive ensemble cast. Directed ...
Anil Kapoor and Nana Patekar are like family and they will definitely return whenever "Welcome 4" will be made, says Akshay Kumar about the two veterans' absence from the franchise's latest entry ...
New Delhi: India all-rounder Nitish Kumar Reddy is in a race against time for the three ODIs against England starting July 14 in Birmingham. TimesofIndia.com has learnt that the BCCI medical team has ...
Vijay Kumar, the acting head of the FDA office that oversees new gene therapies, is stepping down from his role after a year in the job. As Kumar’s tenure atop the Office of Therapeutic Products (OTP) ...